Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 have?
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 has 558 citations in the OpenAlex counts ScholarIQ stores.
When was Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 published?
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 has 2020 year in the ScholarIQ index.
What is the open-access status of Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19?
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 has bronze oa status in the ScholarIQ index.
What is the DOI of Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19?
The DOI for Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 is on the source record.
What is the PMID of Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19?
The PMID for Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 is on the source record.
What is the OpenAlex record for Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19?
The OpenAlex for Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 is on the source record.